Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells

Cell Biology International

Volumn 35, Issue 4, 2011, Pages 321-324

  Hong, Liu ^a   Han, Yu ^a   Li, Shujun ^a   Yang, Jianjun ^a   Gong, Taiqian ^a   Li, Jipeng ^a   Zheng, Jianyong ^a   Zhang, Hongwei ^a   Zhao, Qingchuan ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Leukaemia; ZNRD1

Indexed keywords

GROWTH FACTOR; MICRORNA; MICRORNA 214; MICRORNA 221; MICRORNA 222; MICRORNA 296; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC RIBBON DOMAIN CONTAINING 1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UPREGULATION;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 79952086189     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100506     Document Type: Article

References (20)

1. Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 2009;23:2233-41.
2. Chien MH, Ku CC, Johansson G. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis 2009;30:2005-13.
3. Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370-7.
4. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 2010;125:92-104.
5. Hajighasemi F, Hajighasemi S. Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro. Iran Biomed J 2009;13:157-62.
6. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z, Fan D. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 2005a;4:1936-42.
7. Hong L, Chen Z, Zhang X, Fan D. Zinc ribbon domain containing 1 protein: modulator of multidrug resistance, tumorigenesis and cell cycle. Exp Oncol 2006a;28:258-62.
8. Hong L, Qiao T, Han Y, Han S, Zhang X, Lin T, Gao J, Zhao P, Chen Z, Fan D. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem Cell Biol 2006b;84:199-206.
9. Hong L, Zhang Y, Liu N, Pan Y, Fan D. Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene. Biochem Biophys Res Commun 2004a;321:611-6.
10. Hong L, Zhang Y, Han Y, Guo W, Wang J, Li X, Han Y, Fan D. Preparation and characterization of a novel monoclonal antibody specific to human ZNRD1 protein. Hybrid Hybridomics 2004b;23:65-8.
11. Hong L, Zhao Y, Han Y, Guo W, Jin H, Qiao T, Che Z, Fan D. Mechanisms of growth arrest by zinc ribbon domain-containing 1 in gastric cancer cells. Carcinogenesis 2007;28:1622-8.
12. Hong L, Han Y, Shi R, Shao X, Sun L, Zhang Y, Huang D, Chen Z, Zhang G, Liang J, Hu S, Fan D. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005b;4:60-4.
13. Hong L, Ning X, Shi Y, Zhang Y, Fan D. Reversal of multidrug resistance of gastric cancer cells by down-regulation of ZNRD1 with ZNRD1 siRNA. Br J Biomed Sci 2004c;61:206-10.
14. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009;36:61-74.
15. Maffei R, Martinelli S, Castelli I. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemiaderived Ang2 and VEGF. Leukemia Res 2010;34:312-21.
16. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucoseregulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription RNA. 2009;15:287-93.
17. Vecchiarelli-Federico LM, Cervi D, Haeri M, Li Y, Nagy A, Ben-David Y. Vascular endothelial growth factor-a positive and negative regulator of tumor growth. Cancer Res 2010;70:863-7.
18. Wysoczynski M, Shin DM, Kucia M, Ratajczak MZ. Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications. Int J Cancer 2010;126:371-81.
19. Wang S, Olson EN. AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205-11.
20. Würdinger T, Tannous BA, Saydam O. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008;14(5):382-93.